Effect of Hormone Replacement Therapy on Lupus Activity
NCT00392093
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
108
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran